株探米国株
日本語 英語
エドガーで原本を確認する
0001524472false00015244722024-10-312024-10-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 31, 2024
XYLEM INC.
(Exact name of registrant as specified in its charter)
Indiana 001-35229 45-2080495
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
301 Water Street SE 20003
Washington DC
(Address of principal executive offices) (Zip Code)
(202) 869-9150
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange of which registered
Common Stock, par value $0.01 per share XYL New York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.¨



Item 2.02 Results of Operations and Financial Condition
On October 31, 2024, Xylem Inc. issued a press release announcing its financial results for the quarter ended September 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated by reference herein.
This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
Exhibit
   No.
Description
Press Release issued by Xylem Inc. on October 31, 2024.
104.0 The cover page from Xylem Inc.'s Form 8-K, formatted in Inline XBRL.





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
XYLEM INC.
Date: October 31, 2024 By: /s/ William K. Grogan
William K. Grogan
Senior Vice President & Chief Financial Officer
(Authorized Officer of Registrant)



EX-99.1 2 xyl10312024ex991.htm EX-99.1 Document

Exhibit 99.1
imagea.jpg

Xylem Inc.
301 Water Street SE, Suite 200
Washington, DC 20003
Tel +1.202.869.9150

Contacts: Media Investors
Houston Spencer +1 (914) 240-3046 Keith Buettner +1 (724) 772-1531
Houston.Spencer@xylem.com Keith.Buettner@xylem.com

Xylem Reports Third Quarter 2024 Results and Narrows Full-Year Guidance

•Revenue of $2.1 billion, up 1% on a reported and organic basis
•Earnings per share of $0.89, up 41%; $1.11 on an adjusted basis, up 12%
•Updated full-year revenue guidance of $8.5 billion, up approximately 15% YoY, with organic revenue growth of ~5%
•Narrowing full-year adjusted EPS guidance to $4.22 to $4.24, from $4.18 to $4.28

WASHINGTON, D.C., (October 31, 2024) – Xylem Inc. (NYSE: XYL), a leading global water technology company that empowers customers and communities to build a more water-secure world, today reported third-quarter results. The Company’s total revenue was $2.1 billion, up one percent on a reported and organic basis, and third-quarter earnings per share were up 41 percent on a reported basis and 12 percent on an adjusted basis. Orders grew 8 percent on a reported and organic basis.

“The team delivered strong results in the quarter, with earnings at the high end of guidance, and margin expansion beating our expectations,” said Matthew Pine, Xylem’s President and CEO. “Demand remained resilient, reflected in robust orders growth in all segments, and a healthy book-to-bill. Moderated organic revenue growth in the quarter was driven largely by project timing.”

“Outperformance on margin and earnings was further reinforced by momentum in our integration of Evoqua and by initial impacts from our broader simplification efforts,” Pine continued. “Evoqua integration is ahead of schedule and synergy capture continues to accelerate, giving us confidence in closing the year above target. As a result, we are narrowing our full-year earnings guidance, with continuing focus on sustainable, high-quality earnings and profitable growth.”

Net income was $217 million, or $0.89 per share. Net income margin increased 300 basis points to 10.3 percent. These results are driven by strong operational performance. Adjusted net income was $269 million, or $1.11 per share, which excludes the impacts of amortization of acquired intangible assets, restructuring and realignment costs, gain/loss from sale of businesses, special charges, and tax-related special items.

Third-quarter adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin was 21.2 percent, ­reflecting a year-over-year increase of 140 basis points. Productivity savings and price drove the margin expansion, exceeding the impact of inflation, strategic investments and mix.




1


Outlook

Xylem expects full-year 2024 revenue of $8.5 billion, up approximately 15 percent on a reported basis and up approximately 5 percent on an organic basis.

Full-year 2024 adjusted EBITDA margin is expected to be approximately 20.5 percent. This results in adjusted earnings per share of $4.22 to $4.24 from the previous range of $4.18 to $4.28. Full-year free cash flow conversion to net income is expected to be at least 120 percent.

Further 2024 planning assumptions are included in Xylem’s third-quarter earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Supplemental information on Xylem’s third-quarter earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

###
About Xylem

Xylem (XYL) is a Fortune 500 global water solutions company that empowers customers and communities to build a more water-secure world. Our 23,000 diverse employees delivered combined pro forma revenue of $8.1 billion in 2023, optimizing water and resource management with innovation and expertise. Join us at www.xylem.com and Let’s Solve Water.

Forward-Looking Statements

This press release contains “forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” "contemplate," "predict," “forecast,” “likely,” “believe,” “target,” “will,” “could,” “would,” “should,” "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that: are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control.
2


Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector spending, interest rates, inflation and related monetary policy by governments in response to inflation, and the strength of the residential and commercial real estate markets, on economic activity and our operations; geopolitical events, including the ongoing and possible escalation of the conflicts involving Russia and Ukraine, and the Middle East, as well as regulatory, economic and other risks associated with our global sales and operations, including those related to domestic content requirements applicable to projects receiving governmental funding; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, energy supply, supply chain shortages, logistics challenges, tight labor markets, prevailing price changes, tariffs and other factors; demand for our products, disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents or other disruptions of information technology systems on which we rely, or involving our connected products and services; lack of availability or delays in receiving parts and raw materials from our supply chain, including electronic components (in particular, semiconductors); disruptions in operations at our facilities or that of third parties upon which we rely; uncertainty related to the realization of the benefits and synergies from our acquisition of Evoqua Water Technologies Corp.; safe and compliant treatment and handling of water, wastewater and hazardous materials; failure to successfully execute large projects, including with respect to meeting performance guarantees and customers’ budgets, timelines and safety requirements; our ability to retain and attract leadership and other diverse and key talent, as well as competition for overall talent and labor; defects, security, warranty and liability claims, and recalls related to our products; uncertainty around restructuring and realignment actions and related costs and savings; our ability to execute strategic investments for growth, including related to acquisitions and divestitures; availability, regulation or interference with radio spectrum used by certain of our products; volatility in served markets or impacts on our business and operations due to weather conditions, including the effects of climate change; risks related to our sustainability commitments and related disclosures; fluctuations in foreign currency exchange rates; difficulty predicting our financial results; risk of future impairments to goodwill and other intangible assets; changes in our effective tax rates or tax expenses; financial market risks related to our pension and other defined benefit plans; failure to comply with, or changes in, laws or regulations, including those pertaining to our business conduct, operations, products and services, including anti-corruption, data privacy and security, trade, competition, the environment, climate change and health and safety; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; matters related to intellectual property infringement or expiration of rights; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023 ("2023 Annual Report") and in subsequent filings we make with the Securities and Exchange Commission (“SEC”).

Forward-looking and other statements in this press release regarding our environmental and other sustainability plans and goals are not an indication that these statements are necessarily material to investors, to our business, operating results, financial condition, outlook, or strategy, to our impacts on sustainability matters or other parties, or are required to be disclosed in our filings with the SEC. In addition, historical, current, and forward-looking social, environmental and sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. All forward-looking statements made herein are based on information currently available to us as of the date of this press release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.


3


XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited) (in millions, except per share data)
Three Months Nine Months
For the periods ended March 31, 2024 2023 2024 2023
Revenue from products $ 1,744  $ 1,720  $ 5,236  $ 4,535 
Revenue from services 360  356  1,070  711 
Revenue 2,104  2,076  6,306  5,246 
Cost of revenue from products 1,047  1,043  3,147  2,730 
Cost of revenue from services 273  269  804  555 
Cost of revenue 1,320  1,312  3,951  3,285 
Gross profit 784  764  2,355  1,961 
Selling, general and administrative expenses 445  491  1,404  1,291 
Research and development expenses 55  61  172  172 
Restructuring and asset impairment charges 21  37  57 
Operating income 280  191  742  441 
Interest expense 10  14  35  35 
Other non-operating income, net 11  19 
(Loss) on sale of business (2) —  (6) — 
Income before taxes 269  185  712  425 
Income tax expense 52  33  148  82 
Net income $ 217  $ 152  $ 564  $ 343 
Earnings per share:
Basic $ 0.89  $ 0.63  $ 2.33  $ 1.64 
Diluted $ 0.89  $ 0.63  $ 2.32  $ 1.63 
Weighted average number of shares:
Basic 242.9  240.9  242.5  208.9 
Diluted 243.8  242.2  243.4  210.1 


4


XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(in millions, except per share amounts)
September 30,
2024
December 31,
2023
   
ASSETS
Current assets:
Cash and cash equivalents $ 989  $ 1,019 
Receivables, less allowances for discounts, returns and credit losses of $60 and $56 in 2024 and 2023, respectively
1,707  1,617 
Inventories 1,091  1,018 
Prepaid and other current assets 226  230 
Total current assets 4,013  3,884 
Property, plant and equipment, net 1,158  1,169 
Goodwill 7,593  7,587 
Other intangible assets, net 2,326  2,529 
Other non-current assets 956  943 
Total assets $ 16,046  $ 16,112 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 930  $ 968 
Accrued and other current liabilities 1,105  1,221 
Short-term borrowings and current maturities of long-term debt 17  16 
Total current liabilities 2,052  2,205 
Long-term debt 1,977  2,268 
Accrued post-retirement benefits 332  344 
Deferred income tax liabilities 535  557 
Other non-current accrued liabilities 550  562 
Total liabilities 5,446  5,936 
Stockholders’ equity:
Common Stock – par value $0.01 per share:
Authorized 750.0 shares, issued 259.2 shares and 257.6 shares in 2024 and 2023, respectively
Capital in excess of par value 8,673  8,564 
Retained earnings 2,902  2,601 
Treasury stock – at cost 16.2 shares and 16.0 shares in 2024 and 2023, respectively
(753) (733)
Accumulated other comprehensive loss (232) (269)
Total stockholders’ equity 10,593  10,166 
Non-controlling interests 10 
Total equity 10,600  10,176 
Total liabilities and stockholders’ equity $ 16,046  $ 16,112 

5


XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(in millions)
For the periods ended September 30, 2024 2023
Operating Activities
Net income $ 564  $ 343 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation 191  132 
Amortization 229  167 
Share-based compensation 43  45 
Restructuring and asset impairment charges 37  57 
Loss from sale of business — 
Other, net (4) (20)
Payments for restructuring (24) (12)
Changes in assets and liabilities (net of acquisitions):
Changes in receivables (101) (142)
Changes in inventories (88) (41)
Changes in accounts payable (31) 15 
Changes in accrued and deferred taxes (11) (77)
Other, net (123) (85)
Net Cash – Operating activities 688  382 
Investing Activities
Capital expenditures (221) (177)
Acquisition of businesses, net of cash acquired (5) (476)
Proceeds from sale of business 11  103 
Proceeds from the sale of property, plant and equipment
Cash received from investments
Cash paid for investments (8) (1)
Cash paid for equity investments (4) (58)
Cash received from interest rate swaps —  38 
Cash received from cross-currency swaps 25  25 
Other, net
Net Cash – Investing activities (193) (539)
Financing Activities
Short-term debt issued, net — 
Short-term debt repaid (268) — 
Long-term debt issued, net —  275 
   Long-term debt repaid (13) (155)
Repurchase of common stock (19) (10)
Proceeds from exercise of employee stock options 66  45 
Dividends paid (263) (219)
Other, net (23) (8)
Net Cash – Financing activities (520) (71)
Effect of exchange rate changes on cash (5) (11)
Net change in cash and cash equivalents (30) (239)
Cash and cash equivalents at beginning of year 1,019  944 
Cash and cash equivalents at end of period $ 989  $ 705 
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest $ 49  $ 43 
Income taxes (net of refunds received) $ 160  $ 159 
6


Xylem Inc. Non-GAAP Measures
Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures that we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.
“Organic revenue” and “Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.
“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.
“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” and "Adjusted Segment EBITDA" reflect the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.
“Adjusted EBITDA Margin” and “Adjusted Segment EBITDA Margin” defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.
“Adjusted Operating Income”, “Adjusted Segment Operating Income”, “Adjusted Net Income” and “Adjusted EPS” defined as operating income, segment operating income, net income and earnings per share, adjusted to exclude restructuring and realignment costs, amortization of acquired intangible assets, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.
“Adjusted Operating Margin” and “Adjusted Segment Operating Margin” defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.
“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flows, less capital expenditures, and “Free Cash Flow Conversion” defined as Free Cash Flows divided by net income, excluding the gain on sale of businesses and other non-recurring, significant non-cash impacts, such as non-cash impairment charges and significant deferred tax items. Our definitions of "free cash flow" and "free cash flow conversion" do not consider certain non-discretionary cash payments, such as debt.
"Adjusted Free Cash Flow" defined as free cash flow adjusted for significant cash items for which the corresponding income statement impact does not occur within the same fiscal year.
“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.
“Special charges” defined as non-recurring costs incurred by the Company, such as those related to acquisitions and integrations, divestitures and non-cash impairment charges.
“Tax-related special items” defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.
7


Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Orders
($ Millions)
(As Reported - GAAP) (As Adjusted - Organic) Constant 
Currency
(A) (B) (C) (D) (E)=B+C+D (F) = E/A (G) = (E - C) / A
Orders Orders Change 2024 v. 2023 % Change 2024 v. 2023 Book-to-Bill Acquisitions/
Divestitures
FX
Impact
Change
Adj.
2024 v. 2023
% Change
Adj. 2024 v. 2023
2024 2023
Nine Months Ended September 30
Xylem Inc. 6,534  5,457  1,077  20  % 104  % (886) 197  % 20  %
Water Infrastructure 2,036  1,680  356  21  % 111  % (243) (1) 112  % 21  %
Applied Water 1,382  1,350  32  % 103  % —  35  % %
Measurement & Control Solutions 1,199  1,228  (29) (2) % 86  % —  (1) (30) (2) % (2) %
Water Solutions & Services 1,917  1,199  718  60  % 110  % (643) 80  % 60  %
Quarter Ended September 30
Xylem Inc. 2,201  2,031  170  % 105  % —  (4) 166  % %
Water Infrastructure 700  656  44  % 112  % —  (4) 40  % %
Applied Water 437  422  15  % 98  % —  —  15  % %
Measurement and Control Solutions 386  343  43  13  % 84  % —  (2) 41  12  % 12  %
Water Solutions and Services 678  610  68  11  % 118  % —  70  11  % 11  %
Quarter Ended June 30
Xylem Inc. 2,087  1,856  231  12  % 96  % (265) 11  (23) (1) % 13  %
Water Infrastructure 690  563  127  23  % 109  % (89) 43  % 23  %
Applied Water 465  445  20  % 102  % —  23  % %
Measurement and Control Solutions 384  470  (86) (18) % 80  % —  (85) (18) % (18) %
Water Solutions and Services 548  378  170  45  % 91  % (176) (4) (1) % 46  %
Quarter Ended March 31
Xylem Inc. 2,246  1,570  676  43  % 110  % (621) (1) 54  % 43  %
Water Infrastructure 646  461  185  40  % 113  % (154) (2) 29  % 40  %
Applied Water 480  483  (3) (1) % 110  % —  —  (3) (1) % (1) %
Measurement and Control Solutions 429  415  14  % 93  % —  —  14  % %
Water Solutions and Services 691  211  480  227  % 123  % (467) 14  % 228  %
8



Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Revenue
($ Millions)
(As Reported - GAAP) (As Adjusted - Organic) Constant 
Currency
(A) (B) (C) (D) (E) = B+C+D (F) = E/A (G) = (E - C) / A
Revenue Revenue Change 2024 v. 2023 % Change 2024 v. 2023 Acquisitions /
Divestitures
FX
Impact
Change Adj. 2024 v. 2023 % Change Adj. 2024 v. 2023
2024 2023
Nine Months Ended September 30
Xylem Inc. 6,306  5,246  1,060  20  % (782) 283  % 20  %
Water Infrastructure 1,828  1,541  287  19  % (221) —  66  % 19  %
Applied Water 1,339  1,396  (57) (4) % —  (56) (4) % (4) %
Measurement and Control Solutions 1,402  1,175  227  19  % —  —  227  19  % 19  %
Water Solutions and Services 1,737  1,134  603  53  % (561) 46  % 54  %
Quarter Ended September 30
Xylem Inc. 2,104  2,076  28  % —  (6) 22  % %
Water Infrastructure 623  612  11  % —  (5) % %
Applied Water 447  465  (18) (4) % —  (2) (20) (4) % (4) %
Measurement and Control Solutions 458  413  45  11  % —  (1) 44  11  % 11  %
Water Solutions and Services 576  586  (10) (2) % —  (8) (1) % (1) %
Quarter Ended June 30
Xylem Inc. 2,169  1,722  447  26  % (302) 13  158  % 27  %
Water Infrastructure 631  519  112  22  % (84) 34  % 23  %
Applied Water 456  478  (22) (5) % —  (18) (4) % (4) %
Measurement and Control Solutions 482  384  98  26  % —  100  26  % 26  %
Water Solutions and Services 600  341  259  76  % (218) 42  12  % 76  %
Quarter Ended March 31
Xylem Inc. 2,033  1,448  585  40  % (480) (2) 103  % 40  %
Water Infrastructure 574  410  164  40  % (137) (1) 26  % 40  %
Applied Water 436  453  (17) (4) % —  (1) (18) (4) % (4) %
Measurement and Control Solutions 462  378  84  22  % —  (1) 83  22  % 22  %
Water Solutions and Services 561  207  354  171  % (343) 12  % 171  %
9


Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
Q3 2024 Q3 2023
As Reported Adjustments Adjusted As Reported Adjustments Adjusted
Total Revenue 2,104  —  2,104  2,076  —  2,076 
Operating Income 280  70   a 350  191  124   a 315 
Operating Margin 13.3  % 16.6  % 9.2  % 15.2  %
Interest Expense (10) —  (10) (14) —  (14)
Other Non-Operating Income (Expense) —  — 
Gain/(Loss) from Sale of Business (2) b —  —  —  — 
Income before Taxes 269  72  341  185  124  309 
Provision for Income Taxes (52) (20) c (72) (33) (36) c (69)
Net Income 217  52  269  152  88  240 
Diluted Shares 243.8 243.8  242.2  242.2 
Diluted EPS $ 0.89  $ 0.22  $ 1.11  $ 0.63  $ 0.36  $ 0.99 
a Quarter-to-date: Restructuring & realignment costs: 2024 - $11 million and 2023 - $34 million                                                
Special charges: 2024 - $6 million of acquisition & integration cost and $1 million of other special charges; 2023 - $23 million of acquisition & integration related costs and $1 million of asset impairment charges                                            
Purchase accounting intangible amortization: 2024 - $52 million and 2023 - $66 million
b Gain/Loss from sale of business as per income statement for all periods presented
c Quarter-to-date: 2024 - Net tax impact on pre-tax adjustments (note a and b) of $17 million and other tax special items of $3 million; 2023 - Net tax impact on pre-tax adjustments (note a) of $28 million and other tax special items of $8 million
10


Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
($ Millions)
2024
Q1 Q2 Q3 Q4 Total
Net Income 153  194  217  564 
Net Income Margin 7.5  % 8.9  % 10.3  % 8.9  %
Depreciation 61  62  68  191 
Amortization 73  83  73  229 
Interest Expense (Income), net 18 
Income Tax Expense 43  53  52  148 
EBITDA 337  398  415  1,150 
Share-based Compensation 18  13  12  43 
Restructuring & Realignment 15  29  11  55 
Special Charges 16  13  36 
Loss/(Gain) from sale of business (1)
Adjusted EBITDA 391  452  447  1,290 
Revenue 2,033  2,169  2,104  6,306 
Adjusted EBITDA Margin 19.2  % 20.8  % 21.2  % 20.5  %
2023
Q1 Q2 Q3 Q4 Total
Net Income 99  92  152  266  609 
Net Income Margin 6.8  % 5.3  % 7.3  % 12.6  % 8.3  %
Depreciation 28  41  63  61  193 
Amortization 32  51  84  76  243 
Interest Expense (Income), net 21 
Income Tax Expense 27  22  33  (56) 26 
EBITDA 188  211  338  355  1,092 
Share-based Compensation 12  15  18  15  60 
Restructuring & Realignment 11  36  33  23  103 
Special Charges 25  67  22  22  136 
Loss/(Gain) from sale of business —  —  — 
Adjusted EBITDA 236  329  411  416  1,392 
Revenue 1,448  1,722  2,076  2,118  7,364 
Adjusted EBITDA Margin 16.3  % 19.1  % 19.8  % 19.6  % 18.9  %













11